Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, September 5, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
a) |
Name |
Paul John Chaplin |
|
2. |
Reason for the notification |
||
a) |
Position/status |
President and Chief Executive Officer of Bavarian Nordic A/S |
|
b) |
Initial notification/Amendment |
Initial notification |
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
a) |
Name |
Bavarian Nordic A/S |
|
b) |
LEI |
2138006JCDVYIN6INP51 |
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument Identification code |
Shares
|
|
b) |
Nature of the transaction |
Exercise of warrants |
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
DKK 146.60 |
98,855 |
d) |
Aggregated information - Aggregated volume - Price |
98,855 DKK 14,492,143.00 |
|
e) |
Date of the transaction |
2024-09-05 |
|
f) |
Place of the transaction |
Nasdaq Copenhagen A/S, XCSE |
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
a) |
Name |
Henrik Juuel |
|
2. |
Reason for the notification |
||
a) |
Position/status |
Executive Vice President and Chief Financial Officer of Bavarian Nordic A/S |
|
b) |
Initial notification/Amendment |
Initial notification |
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
a) |
Name |
Bavarian Nordic A/S |
|
b) |
LEI |
2138006JCDVYIN6INP51 |
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument Identification code |
Shares
|
|
b) |
Nature of the transaction |
Exercise of warrants |
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
DKK 146.60 |
42,916 |
d) |
Aggregated information - Aggregated volume - Price |
42,916 DKK 6,291,486.00 |
|
e) |
Date of the transaction |
2024-09-05 |
|
f) |
Place of the transaction |
Nasdaq Copenhagen A/S, XCSE |
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
a) |
Name |
Jean-Christophe May |
|
2. |
Reason for the notification |
||
a) |
Position/status |
Executive Vice President and Chief Commercial Officer of Bavarian Nordic A/S |
|
b) |
Initial notification/Amendment |
Initial notification |
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
a) |
Name |
Bavarian Nordic A/S |
|
b) |
LEI |
2138006JCDVYIN6INP51 |
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument Identification code |
Shares
|
|
b) |
Nature of the transaction |
Exercise of warrants |
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
DKK 155.80 |
7,039 |
d) |
Aggregated information - Aggregated volume - Price |
7,039 DKK 1,096,676.00 |
|
e) |
Date of the transaction |
2024-09-05 |
|
f) |
Place of the transaction |
Nasdaq Copenhagen A/S, XCSE |
About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccine company with a mission to protect and save lives through innovative vaccines. We are a global leader in smallpox and mpox vaccines, supplied to governments to enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit www.bavarian-nordic.com.
Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, rss@bavarian-nordic.com, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600
Company Announcement no. 28 / 2024